Functional biomimetic nanoparticles for drug delivery and theranostic applications in cancer treatment

Science and Technology of Advanced Materials
Lei LiGang Liu

Abstract

Nanotechnology has been extensively utilized in the design and development of powerful strategies for drug delivery and cancer theranostic. Nanoplatforms as a drug delivery system have many advantages such as in vivo imaging, combined drug delivery, extended circulation time, and systemic controlled release. The functional biomimetic drug delivery could be realized by incorporating stimuli-responsive (pH, temperature, redox potential, etc.) properties into the nanocarrier system, allowing them to bypass biological barriers and arrive at the targeted area. In this review, we discuss the role of internal stimuli-responsive nanocarrier system for imaging and drug delivery in cancer therapy. The development of internal stimuli-responsive nanoparticles is highlighted for precision drug delivery applications, with a particular focus on in vivo imaging, drug release performance, and therapeutic benefits.

References

Jan 1, 1991·Virchows Archiv. A, Pathological Anatomy and Histopathology·H InajiA Wada
Feb 1, 1988·Gastroenterology·J N WeitzelJ H Eckfeldt
Jun 2, 1987·Biochemistry·N K SubbaraoK Pongracz
Dec 1, 1984·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J L Wike-HooleyH S Reinhold
Jun 20, 1997·International Journal of Cancer. Journal International Du Cancer·T AbeM Ogawa
Oct 24, 1998·Biochemistry and Molecular Biology International·G BolotJ Portoukalian
Apr 20, 1999·Nature Biotechnology·R WeisslederA Bogdanov
Feb 17, 2000·Biochimica Et Biophysica Acta·M ZignaniJ C Leroux
Mar 22, 2001·Advanced Drug Delivery Reviews·J Kost, R Langer
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Jun 5, 2002·Annual Review of Biochemistry·P Borst, R Oude Elferink
Jun 6, 2002·Drug Discovery Today·Piyush GuptaSanjay Garg
Feb 27, 2003·Journal of Liposome Research·Christopher TurnerMalcolm N Jones
May 10, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Niren MurthyPatrick S Stayton
Oct 25, 2003·Oncogene·Tito Fojo, Susan Bates
Nov 20, 2003·Bioconjugate Chemistry·Ryan TomlinsonRuth Duncan
Mar 20, 2004·Science·Theresa M Allen, Pieter R Cullis
Feb 3, 2005·Nature Reviews. Drug Discovery·Vladimir P Torchilin
Feb 16, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Martin HrubýKarel Ulbrich
Mar 5, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S Moein MoghimiJ Clifford Murray
Mar 22, 2005·International Journal of Pharmaceutics·Dinesh B Shenoy, Mansoor M Amiji
Dec 21, 2005·International Journal of Pharmaceutics·Tatsuhiro IshidaHiroshi Kiwada
Jan 31, 2006·Angewandte Chemie·Rainer Haag, Felix Kratz
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
Jul 21, 2006·The Journal of Physical Chemistry. B·Nick S Norberg, Daniel R Gamelin
Sep 2, 2006·Biological & Pharmaceutical Bulletin·Manju RawatSwarnlata Saraf
Nov 10, 2006·Advanced Drug Delivery Reviews·Vladimir P Torchilin
Nov 28, 2006·Advanced Drug Delivery Reviews·Dirk Schmaljohann
Jul 14, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ping-Shan LaiMing-Jium Shieh
Feb 12, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Srinivas GantaMansoor Amiji
Feb 16, 2008·Journal of Drug Targeting·Suphiya Parveen, Sanjeeb K Sahoo
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kwangjae ChoDong M Shin
Jun 24, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Eun Seong LeeYou Han Bae
Jun 25, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Eiji YubaKenji Kono
Jul 17, 2008·Bioconjugate Chemistry·Veronika KnorrErnst Wagner
Jul 25, 2008·Journal of Colloid and Interface Science·Shigeru TomitaJun-ichi Anzai
Nov 1, 2008·Cancer Research·Vincent T DeVita, Edward Chu
Feb 25, 2009·Expert Opinion on Biological Therapy·Noriko IikuniAntonio La Cava

❮ Previous
Next ❯

Citations

Oct 12, 2019·Current Pharmaceutical Design·Kandasamy SaravanakumarMyeong-Hyeon Wang
Mar 9, 2019·Recent Patents on Nanotechnology·Swayamprakash Patel, Gayatri Patel
Oct 23, 2019·Cellular and Molecular Life Sciences : CMLS·Sanda BocaIoana Berindan-Neagoe
Jul 30, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Lina WuXilin Sun
Jul 6, 2019·Science and Technology of Advanced Materials·Marwa MohamedTatsuhiro Ishida
Nov 21, 2019·International Journal of Molecular Sciences·Balsam R RizeqGheyath K Nasrallah
Jun 14, 2019·Science and Technology of Advanced Materials·Roland HanyKaren Strassel
Sep 18, 2020·Science and Technology of Advanced Materials·Takanori AkagiPeng Mi
May 7, 2020·Advanced Pharmaceutical Bulletin·Dipak Dilip Gadade, Sanjay Sudhakar Pekamwar
Dec 11, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Adrija JhaSrinivas Mutalik
Jul 14, 2019·Seminars in Cancer Biology·Balney RajithaGanji Purnachandra Nagaraju
Nov 15, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hanieh MousazadehNosratollah Zarghami
Mar 5, 2021·International Journal of Nanomedicine·Ruixin JiaYe Bi
Feb 26, 2021·International Journal of Nanomedicine·Zehra EdisMunazza Ijaz
Mar 13, 2021·Frontiers in Chemistry·Ajita JindalAftab Alam
Apr 4, 2021·Pharmaceutics·Rajasekharreddy PalaSurya M Nauli
Apr 23, 2021·Soft Matter·Goutam Ghosh, Lata Panicker
Apr 20, 2021·Colloids and Surfaces. B, Biointerfaces·Rajesh Singh JadonRajeev K Tyagi

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence imaging
Transfection
xenografts
xenograft
enzyme linked immunosorbent assays

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Materials Science & Engineering. C, Materials for Biological Applications
Mengrui LiuGuangxi Zhai
Journal of Controlled Release : Official Journal of the Controlled Release Society
Srinivas GantaMansoor Amiji
© 2022 Meta ULC. All rights reserved